Keymed Biosciences, Inc. (HK:2162)
:2162
Earnings Data
Report Date
Sep 01, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
6.51Last Year’s EPS
-0.34Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
HK:2162 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:2162 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 26, 2026 | HK$57.55 | HK$57.65 | +0.17% |
Aug 26, 2025 | HK$71.25 | HK$72.75 | +2.11% |
Mar 24, 2025 | HK$38.20 | HK$38.00 | -0.52% |
Aug 27, 2024 | HK$31.95 | HK$32.05 | +0.31% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Keymed Biosciences, Inc. (HK:2162) report earnings?
Keymed Biosciences, Inc. (HK:2162) is schdueled to report earning on Sep 01, 2026, TBA (Confirmed).
What is Keymed Biosciences, Inc. (HK:2162) earnings time?
Keymed Biosciences, Inc. (HK:2162) earnings time is at Sep 01, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Keymed Biosciences, Inc. stock?
The P/E ratio of Keymed Biosciences, Inc. is N/A.
What is HK:2162 EPS forecast?
HK:2162 EPS forecast for the fiscal quarter 2026 (Q2) is 6.51.